Myelodysplastic Syndrome (MDS)

End-of-life Care Intensity for Patients With MDS May Be Suboptimal

By

The intensity of end-of-life care for patients with myelodysplastic syndromes may be optimal in terms of hospice use, a recently published study has shown.

Darbepoetin Alfa Reduces Red Blood Cell Transfusions In Patients With Myelodysplastic Syndrome

By

Darbepoetin alfa reduced the incidence of red blood cell transfusions in anemic patients with low and intermediate-1 risk myelodysplastic syndrome, according to phase 3 clinical trial data.

Pretransplant Myeloablative Regimens Confirmed Standard of Care for MDS, AML

Pretransplant Myeloablative Regimens Confirmed Standard of Care for MDS, AML

By

Results of a phase 3 randomized trial support high intensity conditioning with myeloablative regimens prior to allogeneic stem cell transplantation as standard of care for patients with acute myeloid leukemia.

Among Medicare Beneficiaries with MDS, No Association Between Costs of Care, Overall Survival

Among Medicare Beneficiaries with MDS, No Association Between Costs of Care, Overall Survival

By

Overall survival rates for Medicare beneficiaries with myelodysplastic syndrome (MDS) showed little difference related to disease-related costs, according to data presented at the 2015 ASH Annual Meeting in Florida.

Early discharge after intensive AML, MDS chemo can reduce costs, antibiotics use

Early discharge after intensive AML, MDS chemo can reduce costs, antibiotics use

Early discharge after intensive acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) can reduce both costs and use of intravenous antibiotics, according to a new study.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs